We are live on ! Find out more
INGN icon

Inogen

237 hedge funds and large institutions have $3.92B invested in Inogen in 2018 Q2 according to their latest regulatory filings, with 36 funds opening new positions, 75 increasing their positions, 95 reducing their positions, and 25 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more funds holding in top 10

Funds holding in top 10: 24 (+2)

51% more capital invested

Capital invested by funds: $2.59B → $3.92B (+$1.33B)

44% more first-time investments, than exits

New positions opened: 36 | Existing positions closed: 25

4% more funds holding

Funds holding: 228237 (+9)

0.17% less ownership

Funds ownership: 99.36%99.19% (-0.17%)

21% less repeat investments, than reductions

Existing positions increased: 75 | Existing positions reduced: 95

22% less call options, than puts

Call options by funds: $20.9M | Put options by funds: $26.7M

Holders
237
Holders Change
+9
Holders Change %
+3.95%
% of All Funds
5.43%
Holding in Top 10
4
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+100%
% of All Funds
0.09%
New
36
Increased
75
Reduced
95
Closed
25
Calls
$20.9M
Puts
$26.7M
Net Calls
-$5.78M
Net Calls Change
-$1.19M
Name Holding Trade Value Shares
Change
Change in
Stake
DCM
26
Driehaus Capital Management
Illinois
$32.8M +$195K +1,171 +0.7%
Goldman Sachs
27
Goldman Sachs
New York
$32.4M +$6.99M +42,029 +32%
TL
28
Tirschwell & Loewy
New York
$30.6M -$632K -3,800 -2%
Prudential Financial
29
Prudential Financial
New Jersey
$29.4M -$8.4M -50,468 -24%
Lord, Abbett & Co
30
Lord, Abbett & Co
New Jersey
$28.9M +$25.8M +155,108 New
Deutsche Bank
31
Deutsche Bank
Germany
$28M +$13.6M +81,602 +119%
Principal Financial Group
32
Principal Financial Group
Iowa
$27.2M -$118K -711 -0.5%
Loomis, Sayles & Company
33
Loomis, Sayles & Company
Massachusetts
$25.1M -$7.16M -43,038 -24%
CC
34
Chicago Capital
Illinois
$23.1M +$336K +2,018 +2%
Jennison Associates
35
Jennison Associates
New York
$22.3M +$12.9M +77,791 +186%
RSCM
36
Rock Springs Capital Management
Maryland
$22.2M +$1.41M +8,500 +8%
Royal Bank of Canada
37
Royal Bank of Canada
Ontario, Canada
$22.1M -$20.5M -123,429 -51%
Morgan Stanley
38
Morgan Stanley
New York
$21.3M +$9.75M +58,589 +105%
TA
39
Teachers Advisors
New York
$20.6M +$13.2M +79,457 +256%
Thrivent Financial for Lutherans
40
Thrivent Financial for Lutherans
Minnesota
$19.1M -$5.99M -35,990 -26%
Charles Schwab
41
Charles Schwab
California
$17M +$1.03M +6,185 +7%
Federated Hermes
42
Federated Hermes
Pennsylvania
$15.7M -$2.42M -14,523 -15%
AAMU
43
Amundi Asset Management US
Massachusetts
$15.3M +$1.18M +7,094 +9%
Russell Investments Group
44
Russell Investments Group
United Kingdom
$14.8M +$483K +2,905 +4%
TCIM
45
TIAA CREF Investment Management
New York
$14.3M -$2.47M -14,869 -16%
Fuller & Thaler Asset Management
46
Fuller & Thaler Asset Management
California
$13.5M +$48.4K +291 +0.4%
JP Morgan Chase
47
JP Morgan Chase
New York
$12.7M +$1.6M +9,643 +17%
WG
48
Winton Group
United Kingdom
$12.5M +$8.84M +53,133 +383%
BIM
49
Bogle Investment Management
Massachusetts
$12.2M +$9.55M +57,372 +704%
AQR Capital Management
50
AQR Capital Management
Connecticut
$10.9M +$2.77M +16,665 +40%

INGN Hedge Fund Activity: Q2 2018 in Review

237 of the 4,368 institutional investors tracked by Wall St. Rank reported a position in Inogen (INGN) for Q2 2018, worth a combined $3.92B — up 51% from $2.59B a quarter earlier.

Buyers outnumbered sellers: 36 funds opened new INGN positions and 25 closed out — a net gain of 11 holders — while 75 added to existing stakes and 95 trimmed.

The largest buyer was AllianceBernstein, adding an estimated $39.4M. The largest seller was Fidelity Investments, cutting an estimated $43.9M.

  • 237 institutional investors held Inogen (INGN) as of Q2 2018, up from 228 in Q1 2018.
  • Funds reported $3.92B of Inogen stock for Q2 2018, up 51% quarter-over-quarter.
  • 36 funds opened new Inogen positions in Q2 2018 and 25 closed out, a net change of +11 holders.
  • The largest Inogen buyer in Q2 2018 was AllianceBernstein, an estimated $39.4M added.
  • The largest Inogen seller in Q2 2018 was Fidelity Investments, an estimated $43.9M sold.

Based on aggregated 13F filings for Q2 2018.